Biotech Values

[ghmm]

 
 Stock  Product          Stage                   Comments  
  -----  ---------------  ---------------------   -----------------------------  
  NTII   Viprinex         Phase 3                 Interim analysis January '09.  Stroke Drug, high chance of failure.  
  BPAX   Libigel          Phase 3 ~2010 Submit    Adequate Safety?  
  EPIX   Vasovist         PDUFA 12/30/08          FDA initial rejected saying 2 more studies needed.  Allowed reread company states  
                                                  results very positive.  Looking to sell outright on approval.  
  RPRX   Proellex         Phase 3                 Uterine fibroids